Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

• Status: Unknown status
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study was to investigate the efficacy of aripiprazole in management of pre-existing neuroleptic-induced tardive dyskinesia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
• Collaborator: Department of Health
• Treatments: Antipsychotic Agents; Aripiprazole

Criteria

Inclusion Criteria:

• Female patients must agree to prevent from being pregnant during trial periods

• Meet psychotic disorder or mood disorder criteria of DSM-IV

• Patients must have psychiatric diseases that need to use antipsychotics for a long time

• They must meet DSM-IV research criteria for neuroleptics induce tardive dyskinesia

• No clinical significant major systemic diseases

• No special neurological diseases which would influence the assessment for EPS or TD

• Mentality is better than mild mental retardation

• Patients or .legal representatives agree to join in the research and sign informed consent.

Exclusion Criteria:

• Unstable major systemic diseases

• Had neurological disorder influenced to EPS assessment

• Substance abuse or dependence other then coffee or tobacco within 6 months before study